Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Korean Regulatory Overhaul To Cut R&D, Approval Periods

This article was originally published in PharmAsia News

Executive Summary

In its latest series of broad support measures for the biopharma sector, South Korea is to ease selected regulatory rules to shorten R&D and approval periods, and ensure the prompt and stable supply of drugs essential for public health.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register